Cite
HARVARD Citation
Johnston, K. et al. (2022). Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis. Expert review of pharmacoeconomics & outcomes research. pp. 155-166. [Online].